Ignite Creation Date:
2024-05-05 @ 11:30 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00069758
Status:
COMPLETED
Last Update Posted:
2014-05-09
First Post:
2003-09-30
Brief Title:
Safety and Activity of SDX-105 Bendamustine in Patients With Rituximab Refractory Non-Hodgkins Lymphoma
Sponsor:
Cephalon
Organization:
Teva Branded Pharmaceutical Products RD Inc
Organization Data
Organization:
Teva Branded Pharmaceutical Products RD Inc
Class:
INDUSTRY
Study ID:
SDX-105-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Cephalon
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None